CRM
67
2
PVH
62
5
KHC
24
13
XRX
44
3
CMG
72
5
PYPL
54
2
TROW
56
5
WFC
79
4
CL
58
2
AN
58
4
PSX
47
2
GOOG
50
-3
RIG
60
2
GE
67
2
CTSH
56
2
A
43
2
TSCO
49
5
IBM
58
-2
VZ
50
3
KLAC
47
4
CRM
67
2
PVH
62
5
KHC
24
13
XRX
44
3
CMG
72
5
PYPL
54
2
TROW
56
5
WFC
79
4
CL
58
2
AN
58
4
PSX
47
2
GOOG
50
-3
RIG
60
2
GE
67
2
CTSH
56
2
A
43
2
TSCO
49
5
IBM
58
-2
VZ
50
3
KLAC
47
4
Financhill
Back

Zimmer Biomet Holdings 10K Form

Buy
60

ZBH
Zimmer Biomet Holdings

Last Price:
110.30
Seasonality Move:
10.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZBH News And Ratings

See the #1 stock for the next 7 days that we like better than ZBH

ZBH Financial Statistics

Sales & Book Value

Annual Sales: $7.39B
Cash Flow: $368.6M
Price / Cash Flow: 18.04
Annual Sales: $62.00
Price / Book: 1.77

Profitability

EPS (TTM): 5.26000
Net Income (TTM): $1.08B
Gross Margin: $5.31B
Return on Equity: 8.63%
Return on Assets: 5.04%

Zimmer Biomet Holdings Earnings Forecast

Key Zimmer Biomet Holdings Financial Ratios

  • The Gross Profit Margin over the past 24 years for ZBH is 71.82%.
  • The Selling, General & Administrative Expenses for ZBH have been equal to 38.39% of Gross Profit Margin.
  • The Research & Development expenses have been 6.20% of Revenue.
  • The Interest Expense is 19.65% of Operating Income.
  • The Net Earning history of ZBH is 13.85% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Zimmer Biomet Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ZBH
CUSIP: 98956P
Website: zimmerbiomet.com

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 1.36
Quick Ratio: 0.57

Price-to-Earnings

Trailing P/E Ratio: 22.59
Forward P/E Ratio: 12.85

ZBH Technical Analysis vs Fundamental Analysis

Buy
60
Zimmer Biomet Holdings (ZBH) is a Buy

Is Zimmer Biomet Holdings a Buy or a Sell?